Fundraising Fox

Averna Therapeutics

Watertown, US · Founded 2022 · Delaware corporation · 2 known investors

Creates gene therapies that integrate therapeutic genes into patients' genomes to treat genetic disorders.

Healthtech

Founders & leadership

TB
Thomas BarnesChief Executive Officer/President
RM
Richard MorrisChief Financial Officer

Board

RA
Roy AmariglioBoard director
NO
Nick OlsenBoard director
SSStephen Squinto
Stephen SquintoinBoard directorVenture Partner at OrbiMed
MS
Michal SilverbergBoard director
RP
Raju PrasadBoard director
TZTal Zaks
Tal ZaksinBoard directorPartner at OrbiMed
HC
Henry ChenBoard director
DM
Dylan MorrisBoard director

Investors · 2

Reported raises · per SEC filings

Form D private placements

$85M disclosed across 1 round · 2024

$85MraisedMar 2026 · 13 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas BarnesDirector, Executive Officer
  • Roy AmariglioDirector
  • Nick OlsenDirector
  • Stephen SquintoDirector
  • Richard MorrisExecutive Officer
  • Michal SilverbergDirector
  • Raju PrasadDirector
  • Tal ZaksDirector, Executive Officer
  • Henry ChenDirector
  • Dylan MorrisDirector
Offering amount
$85M
Amount sold
$85M
First sale
Apr 2024
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Averna Therapeutics do?
Creates gene therapies that integrate therapeutic genes into patients' genomes to treat genetic disorders.
Who are Averna Therapeutics's investors?
Averna Therapeutics's investors include Deep Insight, OrbiMed.
How much funding has Averna Therapeutics raised?
Averna Therapeutics has disclosed $85M raised across 1 round.
Where is Averna Therapeutics headquartered?
Averna Therapeutics is headquartered in Watertown, US.